Neuropathic pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.18 to 80 years old patients with acute thoracodorsal herpes zoster neuralgia (within 1 month), VAS score above 6; 2.Patients agree to bear the risk of thoracic paravertebral block and consent to treatment. 3.Patients must understand the research process and evaluation, agree to participate in this trial, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Individuals who have difficulty understanding the mechanism of thoracic paravertebral block or those who refuse the procedure. 2. Known allergies to any medications such as ropivacaine, compounded betamethasone injection, lidocaine injection, etc. 3. Patients who are unable to tolerate the thoracic paravertebral block procedure. 4. Patients with concurrent infections in respiratory system, urinary system, or other related organs. 5.Patients with moderate to severe liver or kidney dysfunction (ALT/AST > 80U/L; creatinine clearance < 10ml/min). 6.Patients with serious immunological disorders. 7. Individuals with local puncture site infection, injury, or pregnancy. 8. Patients currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Absolute values of T lymphocyte subsets;NRS; | — |
Secondary
| Measure | Time frame |
|---|---|
| CRP;the doses of oral drugs; | — |
Countries
China
Contacts
Huishan District People's Hospital of Wuxi